{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:42:51Z","timestamp":1792507371977,"version":"4.5.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a severe adult-onset autoinflammatory disease caused by somatic mutations in the UBA1 gene, disrupting cytoplasmic ubiquitin-activating enzyme E1 function in hematopoietic progenitors. Its pathogenesis remains poorly understood, particularly the mechanisms by which UBA1 mutations disrupt myeloid cell function in the context of inflammatory stimuli. Here, we combine a genetically engineered THP-1 monocytic model with ex vivo analyses of blood and tissue samples from patients with VEXAS syndrome to investigate the consequences of the canonical UBA1M41V mutation. We show that UBA1-mutated monocytes exhibit tumor necrosis factor \u03b1 (TNF-\u03b1)\u2013induced cell death, characterized by receptor-interacting serine\/threonine-protein kinase 1 (RIPK1) phosphorylation, and mixed lineage kinase domain-like\u2013 and caspase-8\u2013mediated cell death. Importantly, we extend these findings to patient-derived CD14+ sorted cells, confirming that these cells undergo aberrant apoptotic and necroptotic cell death. Mechanistically, activation of these cell death pathways appears to be promoted by defective NF-\u03baB\u2013dependent transcriptional responses and reduced cFLIP(L) expression following TNF-\u03b1 stimulation. UBA1-mutated monocytes also display blunted cytokine responses to Toll-like receptor (TLR) agonists despite preserved TLR expression, linked to an impaired NF-\u03baB response. UBA1M41V-derived macrophages exhibit a proinflammatory transcriptional profile with increased chemokine secretion that promotes monocyte recruitment. In addition, these UBA1-mutated macrophages display impaired efferocytosis due to lysosomal dysfunction. Together, these findings reveal a pathogenic axis in VEXAS syndrome linking UBA1 loss of function and defective ubiquitination to RIPK1-mediated inflammatory cell death, impaired antimicrobial signaling, and defective resolution mechanisms. Our study provides novel mechanistic insights into the myeloid dysfunction underlying inflammation and cytopenia in VEXAS syndrome and supports the therapeutic targeting of inflammatory cell death pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031593","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:37:57Z","timestamp":1772476677000},"page":"2944-2957","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Inflammatory cell death and monocyte dysfunction in VEXAS syndrome"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-1218","authenticated-orcid":false,"given":"Paul","family":"Breillat","sequence":"first","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"2Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-217X","authenticated-orcid":false,"given":"Samuel J.","family":"Magaziner","sequence":"additional","affiliation":[{"name":"3Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4326-1724","authenticated-orcid":false,"given":"St\u00e9phane","family":"Camus","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-840X","authenticated-orcid":false,"given":"L\u00e9a","family":"Dionet","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8573-7520","authenticated-orcid":false,"given":"Benjamin","family":"De Valence","sequence":"additional","affiliation":[{"name":"4Centre International de Recherche en Infectiologie, Centre National de la Recherche Scientifique UMR5308, INSERM U1111, Universit\u00e9 Claude Bernard Lyon 1, \u00c9cole Normale Sup\u00e9rieure de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2341-6848","authenticated-orcid":false,"given":"Pierre","family":"Sohier","sequence":"additional","affiliation":[{"name":"5Department of Pathology, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Centre-Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4692-1093","authenticated-orcid":false,"given":"Amine","family":"Majdi","sequence":"additional","affiliation":[{"name":"6Laboratory of Integrative Cancer Immunology, INSERM, Paris, France"},{"name":"7Equipe Labellis\u00e9e Ligue Contre le Cancer, Paris, France"},{"name":"8Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Delcros","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pallotti","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-9805","authenticated-orcid":false,"given":"Nadia","family":"Rivet","sequence":"additional","affiliation":[{"name":"9Innovative Therapies in Haemostasis, INSERM, Universit\u00e9 de Paris, Paris, France"},{"name":"10Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique\u2013H\u00f4pitaux de Paris, Georges Pompidou European Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chevalier","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Poux","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3742-2850","authenticated-orcid":false,"given":"Athena","family":"Lam","sequence":"additional","affiliation":[{"name":"3Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-5905","authenticated-orcid":false,"given":"Pierre-Louis","family":"Tharaux","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-6987","authenticated-orcid":false,"given":"Olivia","family":"Lenoir","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-1755","authenticated-orcid":false,"given":"Abdelrahim","family":"Zoued","sequence":"additional","affiliation":[{"name":"4Centre International de Recherche en Infectiologie, Centre National de la Recherche Scientifique UMR5308, INSERM U1111, Universit\u00e9 Claude Bernard Lyon 1, \u00c9cole Normale Sup\u00e9rieure de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-4057","authenticated-orcid":false,"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[{"name":"11Centre National de la Recherche Scientifique UMR8104, INSERM U1016, Institut Cochin, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"12Hematology Laboratory, Assistance Publique\u2013H\u00f4pitaux de Paris, Centre-Universit\u00e9 de Paris Cit\u00e9, Cochin Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Beck","sequence":"additional","affiliation":[{"name":"3Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY"},{"name":"13Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York, NY"},{"name":"14Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-7336","authenticated-orcid":false,"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"1INSERM U970, Paris Centre de Recherche Cardiovasculaire, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"2Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"27","key":"2026061111221835100_bib1","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"2026061111221835100_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jama.2022.24836","article-title":"Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population","volume":"329","author":"Beck","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"2026061111221835100_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"issue":"16","key":"2026061111221835100_bib4","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"2026061111221835100_bib5","first-page":"1590","article-title":"VEXAS syndrome: a novelty in MDS landscape","volume":"12","author":"Templ\u00e9","year":"2022","journal-title":"Diagn Basel Switz"},{"issue":"11","key":"2026061111221835100_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1182\/blood.2023023723","article-title":"Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes","volume":"144","author":"Sirenko","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2026061111221835100_bib7","first-page":"244","article-title":"Spectrum of clonal hematopoiesis in VEXAS syndrome","volume":"142","author":"Gutierrez-Rodrigues","year":"2023","journal-title":"Blood"},{"issue":"3","key":"2026061111221835100_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ard-2023-224819","article-title":"Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry","volume":"83","author":"de Valence","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2026061111221835100_bib9","doi-asserted-by":"crossref","first-page":"ofae405","DOI":"10.1093\/ofid\/ofae405","article-title":"Opportunistic infections, mortality risk, and prevention strategies in patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome","volume":"11","author":"Czech","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"2026061111221835100_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/keae087","article-title":"Susceptibility to mycobacterial infection in VEXAS syndrome","volume":"64","author":"Riescher","year":"2025","journal-title":"Rheumatology"},{"issue":"16","key":"2026061111221835100_bib11","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.2024028216","article-title":"Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome","volume":"146","author":"Breillat","year":"2025","journal-title":"Blood"},{"issue":"11","key":"2026061111221835100_bib12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2026061111221835100_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40164-022-00262-5","article-title":"Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome","volume":"11","author":"Lacombe","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"2026061111221835100_bib14","doi-asserted-by":"crossref","first-page":"e20241047","DOI":"10.1084\/jem.20241047","article-title":"Primary disorders of polyubiquitination: dual roles in autoinflammation and immunodeficiency","volume":"222","author":"Spaan","year":"2025","journal-title":"J Exp Med"},{"issue":"13","key":"2026061111221835100_bib15","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2022016985","article-title":"Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis","volume":"140","author":"Ferrada","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2026061111221835100_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res"},{"issue":"2","key":"2026061111221835100_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41418-020-00703-w","article-title":"The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities","volume":"28","author":"Damgaard","year":"2021","journal-title":"Cell Death Differ"},{"issue":"8","key":"2026061111221835100_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","article-title":"Disorders of ubiquitylation: unchained inflammation","volume":"18","author":"Beck","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"17","key":"2026061111221835100_bib19","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.cell.2021.07.026","article-title":"Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death","volume":"184","author":"Taft","year":"2021","journal-title":"Cell"},{"issue":"6","key":"2026061111221835100_bib20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cell.2018.07.041","article-title":"TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging","volume":"174","author":"Xu","year":"2018","journal-title":"Cell"},{"issue":"6","key":"2026061111221835100_bib21","doi-asserted-by":"crossref","first-page":"e20222171","DOI":"10.1084\/jem.20222171","article-title":"Dominant negative OTULIN-related autoinflammatory syndrome","volume":"221","author":"Davidson","year":"2024","journal-title":"J Exp Med"},{"issue":"7","key":"2026061111221835100_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/cdd.2017.46","article-title":"CYLD, A20 and OTULIN deubiquitinases in NF-\u03baB signaling and cell death: so similar, yet so different","volume":"24","author":"Lork","year":"2017","journal-title":"Cell Death Differ"},{"issue":"12","key":"2026061111221835100_bib23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.2457","article-title":"Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency","volume":"13","author":"Boisson","year":"2012","journal-title":"Nat Immunol"},{"issue":"1","key":"2026061111221835100_bib24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41467-024-44811-4","article-title":"VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation","volume":"15","author":"Kosmider","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"2026061111221835100_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"20","key":"2026061111221835100_bib26","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.1901179116","article-title":"Targeting RIPK1 for the treatment of human diseases","volume":"116","author":"Degterev","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026061111221835100_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41584-020-0455-8","article-title":"Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease","volume":"16","author":"Anderton","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"2026061111221835100_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","article-title":"More to life than NF-\u03baB in TNFR1 signaling","volume":"37","author":"Ting","year":"2016","journal-title":"Trends Immunol"},{"issue":"12","key":"2026061111221835100_bib29","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/MCB.21.12.3964-3973.2001","article-title":"NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling","volume":"21","author":"Kreuz","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"23","key":"2026061111221835100_bib30","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1038\/sj.emboj.7601423","article-title":"An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway","volume":"25","author":"Nakajima","year":"2006","journal-title":"EMBO J"},{"key":"2026061111221835100_bib31","doi-asserted-by":"crossref","first-page":"101832","DOI":"10.1016\/j.smim.2023.101832","article-title":"The role of caspase-8 in inflammatory signalling and pyroptotic cell death","volume":"70","author":"Pang","year":"2023","journal-title":"Semin Immunol"},{"issue":"46","key":"2026061111221835100_bib32","doi-asserted-by":"crossref","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","article-title":"Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection","volume":"115","author":"Sarhan","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2026061111221835100_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41419-024-06871-8","article-title":"Differential signalling requirements for RIPK1-dependent pyroptosis in neutrophils and macrophages","volume":"15","author":"Yow","year":"2024","journal-title":"Cell Death Dis"},{"issue":"1","key":"2026061111221835100_bib34","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1038\/s41467-020-19935-y","article-title":"Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"2026061111221835100_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.immuni.2014.03.002","article-title":"Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli","volume":"40","author":"Duffy","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"2026061111221835100_bib36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2022.10.052","article-title":"Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases","volume":"88","author":"Zakine","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2026061111221835100_bib37","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41591-025-03623-9","article-title":"Mechanisms of hematopoietic clonal dominance in VEXAS syndrome","volume":"31","author":"Molteni","year":"2025","journal-title":"Nat Med"},{"issue":"8099","key":"2026061111221835100_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41586-025-09815-0","article-title":"Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome","volume":"649","author":"Narendra","year":"2026","journal-title":"Nature"},{"issue":"5","key":"2026061111221835100_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41590-024-01817-w","article-title":"Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency","volume":"25","author":"Oda","year":"2024","journal-title":"Nat Immunol"},{"issue":"2","key":"2026061111221835100_bib40","doi-asserted-by":"crossref","first-page":"rkae065","DOI":"10.1093\/rap\/rkae065","article-title":"Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome","volume":"8","author":"Adachi","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"2026061111221835100_bib41","doi-asserted-by":"crossref","first-page":"701564","DOI":"10.3389\/fphar.2021.701564","article-title":"Necroptosis: a novel pathway in neuroinflammation","volume":"12","author":"Yu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"2026061111221835100_bib42","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1038\/s41467-025-59890-0","article-title":"In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome","volume":"16","author":"Mizumaki","year":"2025","journal-title":"Nat Commun"},{"key":"2026061111221835100_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2023.02.001","article-title":"Cellular mechanisms underlying the impairment of macrophage efferocytosis","volume":"254","author":"Ma","year":"2023","journal-title":"Immunol Lett"},{"key":"2026061111221835100_bib44","doi-asserted-by":"crossref","first-page":"839248","DOI":"10.3389\/fcell.2022.839248","article-title":"Efferocytosis and its role in inflammatory disorders","volume":"10","author":"Ge","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2026061111221835100_bib45","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.192.9.1261","article-title":"Legionella pneumophila replication vacuoles mature into acidic, endocytic organelles","volume":"192","author":"Sturgill-Koszycki","year":"2000","journal-title":"J Exp Med"},{"key":"2026061111221835100_bib46","doi-asserted-by":"crossref","first-page":"595502","DOI":"10.3389\/fcimb.2020.595502","article-title":"The interplay of host lysosomes and intracellular pathogens","volume":"10","author":"Sachdeva","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2026061111221835100_bib47","doi-asserted-by":"crossref","first-page":"127503","DOI":"10.1016\/j.micres.2023.127503","article-title":"Subversion strategies of lysosomal killing by intracellular pathogens","volume":"277","author":"Teixeira","year":"2023","journal-title":"Microbiol Res"},{"issue":"8","key":"2026061111221835100_bib48","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/s41375-025-02671-x","article-title":"Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome","volume":"39","author":"Clough","year":"2025","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/24\/2944\/2525819\/blood_bld-2025-031593-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/24\/2944\/2525819\/blood_bld-2025-031593-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:22:28Z","timestamp":1781191348000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/24\/2944\/566891\/Inflammatory-cell-death-and-monocyte-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":48,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,6,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031593","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,11]]},"published":{"date-parts":[[2026,6,11]]}}}